MedTech Bridge: Successful and efficient trans-Atlantic commercialization for ambitious EU medtech companies
MedTech Bridge is your go-to-market partner for US commercialization and expansion . We help ambitious European medtech companies navigate the complexities of entering, commercializing and scaling in the US through a highly relational, network-driven approach.
MedTech Bridge is a network-based platform providing members with ongoing access to a growing network of 300+ senior advisors and 800+ medtech and startup colleagues across the US . Rather than providing snapshot consulting, we aim to follow and support our member companies over the long term, giving them access to the right expertise, relationships and opportunities as their needs evolve.
MedTech Bridge provides access to webinars and direct interactions with US experts, US delegations, participation in US medtech events, and virtual and face-to-face meetings with relevant industry, commercial, research and investment contacts — and much more.
Through the network, members can connect with experienced professionals and industry leaders across the full medtech commercialization journey, including US go-to-market, reimbursement, regulatory affairs, clinical adoption, market access, manufacturing, supply chain, distribution, financing and strategic partnerships .
Our experts engage directly with companies, take the time to understand their technology, business model and ambitions, and help address critical questions such as:
- Where does your solution fit within the US healthcare system?
- Who are your early adopters, customers and strategic partners?
- What clinical behaviour needs to change to drive adoption?
- Who are your key competitors and how should you differentiate?
- What reimbursement and market-access pathway should you pursue?
- What regulatory and clinical requirements need to be addressed?
- How should you establish your US manufacturing, supply chain and commercial setup?
- Which investors, research institutions, industry partners and other stakeholders should you engage?
The value is in the relationship over time. Members can access different experts and resources as their company progresses from market assessment and regulatory preparation to first customers, commercial scaling and broader US expansion.
”And there is no fixed endpoint. Sometimes a mentor becomes an advisor, board member or fractional CxO – and that is exactly the kind of long-term relationship we aim to create.”